quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:31:04·1421d
INSIDERFiling
Genocea Biosciences Inc. logo

SEC Form 4: Clark William D sold $7,234 worth of shares (117,244 units at $0.06), decreasing direct ownership by 28% to 308,400 units

GNCA· Genocea Biosciences Inc.
Health Care
Original source

Companies

  • GNCA
    Genocea Biosciences Inc.
    Health Care

Related

  • SEC1410d
    SEC Form 15-12B filed by Genocea Biosciences Inc.
  • SEC1411d
    SEC Form EFFECT filed by Genocea Biosciences Inc.
  • SEC1411d
    SEC Form EFFECT filed by Genocea Biosciences Inc.
  • SEC1414d
    SEC Form POS AM filed by Genocea Biosciences Inc.
  • SEC1414d
    SEC Form POS AM filed by Genocea Biosciences Inc.
  • SEC1416d
    SEC Form EFFECT filed by Genocea Biosciences Inc.
  • SEC1416d
    SEC Form EFFECT filed by Genocea Biosciences Inc.
  • NEWS1418d
    The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022